Basics India Globalization Capital, Inc. India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats. IPO Date: June 1, 2006 Sector: Industrials Industry: Trading Companies and Distributors Market Cap: $28.49M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 5.49% Avg Daily Range (30 D): $0.01 | 3.61% Avg Daily Range (90 D): $0.01 | 3.80% Institutional Daily Volume Avg Daily Volume: .79M Avg Daily Volume (30 D): 3.79M Avg Daily Volume (90 D): 1.42M Trade Size Avg Trade Size (Sh.): 343 Avg Trade Size (Sh.) (30 D): 477 Avg Trade Size (Sh.) (90 D): 482 Institutional Trades Total Inst.Trades: 85 Avg Inst. Trade: $2.55M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.15M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 473.34K     News Jul 10, 2025 @ 5:00 PM Cannabinoid Agonist Clinical Trial Pipeline Appear... Source: Delveinsight Jul 6, 2023 @ 12:03 PM Why VBI Vaccines Are Trading Lower By Over 23%; He... Source: Lisa Levin Mar 20, 2023 @ 12:45 PM IGC Announces Rebranding, Changes Name to IGC Pha... Source: IGC Pharma, Inc. Feb 15, 2023 @ 12:41 AM IGC Reports Financial Results for Third Fiscal Qua... Source: INDIA GLOBALIZATION CAPITAL INC. Feb 8, 2023 @ 1:30 PM IGC to be Featured in Feb. 10 Radius Research Inve... Source: INDIA GLOBALIZATION CAPITAL INC. Financials   TTM Q4 2025 FY 2025 Basic EPS $-.09 $-.09 Diluted EPS $-.09 $-.09 Revenue $ 1.27M $ $ 1.27M Gross Profit $ .62M $ $ .62M Net Income / Loss $ -7.12M $ $ -7.12M Operating Income / Loss $ -7.45M $ $ -7.45M Cost of Revenue $ .65M $ $ .65M Net Cash Flow $ -.79M $ $ -.79M PE Ratio     Splits Apr 19, 2013:   1:10